Mycophenolate Mofetil in Systemic Sclerosis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Diffuse Cutaneous Systemic Sclerosis
Interventions
DRUG

Mycophenolate Mofetil

Mycophenolate 3000 mg each day

Trial Locations (1)

02118

Boston University School of Medicine, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aspreva Pharmaceuticals

INDUSTRY

lead

Boston University

OTHER

NCT00433186 - Mycophenolate Mofetil in Systemic Sclerosis | Biotech Hunter | Biotech Hunter